Skip to Content
Celebrating Canada's 2SLGBTQI+ Communities

A Look Back At Our 2020 Cover Stories

A look back at our 2020 cover stories…

As we get ready to say goodbye to 2020, we’re continuing to look back at the past year. Ready for a read or two? Here’s a look back at our 2020 cover stories…with links, of course!

January/February 2020 Cover Story: Yvie Oddly Is Keeping It Weird
By Bianca Guzzo
IN chatted with the current reigning queen on what she’s learned since being crowned, advice to future Ru girls, and being authentic both on and off screen…
READ…

March/April 2020 Cover Story: It’s Time To Give Lesbians The Credit They Deserve
By Courtney Hardwick
April 26th is Lesbian Visibility Day…
READ…

May/June 2020: Celebrating 10 Years Of IN Magazine
In May, IN celebrates its 10th anniversary. Here, we revisit all of our memorable, groundbreaking – and, in some cases, hilariously dated – covers!
READ…

July/August 2020 Cover Story: A Brief History Of Toronto’s First Pride
By Christopher Turner
Toronto’s first “Gay Day Picnic” was held on the beach at Hanlan’s Point on Sunday, August 1, 1971…
READ…

September/October 2020 Cover Story: The LGBTQ Debt To The Civil Rights Movement
By Olivia Nuamah
Racialized communities have played a crucial role in the fight for LGBTQ liberation; let’s not forget that.
READ…

November/December 2020 Cover Story: Meet The Muxes, Mexico’s Third Gender
By Christopher Turner
In the southern state of Oaxaca, there are three genders: male, female and muxe. What can we learn from that?…
READ…

Related Articles

July 17, 2024 / Latest Life

A Gay Climbing Proposal On The Summit Of Denali

These climbers got engaged on North America’s tallest mountain

July 15, 2024 / Latest Life

Friends Of Ruby: Comprehensive Support Services For 2SLGBTQIA+ Youth

Empowering Canada’s vulnerable youth through mental health, housing and community support programs

July 9, 2024 / Health & Fitness Latest Life

Gilead’s Twice-Yearly Shot To Prevent HIV Succeeds In Phase 3 Trial

For the very first time, an HIV PrEP drug candidate has shown zero infections in a late-stage trial

POST A COMMENT

Your email address will not be published. Required fields are marked *